Procaps Group, S.A Cost of Goods Sold 2020-2023 | PROCF
Procaps Group, S.A cost of goods sold from 2020 to 2023. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Procaps Group, S.A Annual Cost of Goods Sold
(Millions of US $) |
| 2022 |
$170 |
| 2021 |
$174 |
| 2020 |
$140 |
| 2020 |
$ |
| 2019 |
$142 |
| 2019 |
$ |
| 2018 |
$ |
Procaps Group, S.A Quarterly Cost of Goods Sold
(Millions of US $) |
| 2023-09-30 |
$50 |
| 2023-06-30 |
$49 |
| 2023-03-31 |
$38 |
| 2022-12-31 |
$49 |
| 2022-09-30 |
$43 |
| 2022-06-30 |
$40 |
| 2022-03-31 |
$39 |
| 2021-12-31 |
$51 |
| 2021-09-30 |
$45 |
| 2021-06-30 |
$41 |
| 2021-03-31 |
$38 |
| 2020-12-31 |
$109 |
| 2020-09-30 |
$32 |
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
